These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 25765123

  • 1. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.
    Flanagan EP, Baker MC, Perkerson RB, Duffy JR, Strand EA, Whitwell JL, Machulda MM, Rademakers R, Josephs KA.
    Dement Geriatr Cogn Disord; 2015; 39(5-6):281-6. PubMed ID: 25765123
    [Abstract] [Full Text] [Related]

  • 2. GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil.
    Takada LT, Bahia VS, Guimarães HC, Costa TV, Vale TC, Rodriguez RD, Porto FH, Machado JC, Beato RG, Cesar KG, Smid J, Nascimento CF, Grinberg LT, Brucki SM, Maximino JR, Camargos ST, Chadi G, Caramelli P, Nitrini R.
    Alzheimer Dis Assoc Disord; 2016; 30(4):310-317. PubMed ID: 27082848
    [Abstract] [Full Text] [Related]

  • 3. Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.
    Tang M, Gu X, Wei J, Jiao B, Zhou L, Zhou Y, Weng L, Yan X, Tang B, Xu J, Shen L.
    Neurobiol Aging; 2016 Oct; 46():235.e11-5. PubMed ID: 27311648
    [Abstract] [Full Text] [Related]

  • 4. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H.
    Neurology; 2016 Sep 27; 87(13):1329-36. PubMed ID: 27581216
    [Abstract] [Full Text] [Related]

  • 5. Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Nonamyloid Logopenic Variant.
    Saracino D, Ferrieux S, Noguès-Lassiaille M, Houot M, Funkiewiez A, Sellami L, Deramecourt V, Pasquier F, Couratier P, Pariente J, Géraudie A, Epelbaum S, Wallon D, Hannequin D, Martinaud O, Clot F, Camuzat A, Bottani S, Rinaldi D, Auriacombe S, Sarazin M, Didic M, Boutoleau-Bretonnière C, Thauvin-Robinet C, Lagarde J, Roué-Jagot C, Sellal F, Gabelle A, Etcharry-Bouyx F, Morin A, Coppola C, Levy R, Dubois B, Brice A, Colliot O, Gorno-Tempini ML, Teichmann M, Migliaccio R, Le Ber I, French Research Network on FTD/FTD-ALS.
    Neurology; 2021 Jul 06; 97(1):e88-e102. PubMed ID: 33980708
    [Abstract] [Full Text] [Related]

  • 6. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
    Whitwell JL, Boeve BF, Weigand SD, Senjem ML, Gunter JL, Baker MC, DeJesus-Hernandez M, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Jack CR, Josephs KA.
    Eur J Neurol; 2015 May 06; 22(5):745-52. PubMed ID: 25683866
    [Abstract] [Full Text] [Related]

  • 7. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
    Kim EJ, Kwon JC, Park KH, Park KW, Lee JH, Choi SH, Jeong JH, Kim BC, Yoon SJ, Yoon YC, Kim S, Park KC, Choi BO, Na DL, Ki CS, Kim SH.
    Neurobiol Aging; 2014 May 06; 35(5):1213.e13-7. PubMed ID: 24387985
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW, Keshavan A, Fox NC, Warren JD, Schott JM, Zetterberg H, Rohrer JD.
    Alzheimers Res Ther; 2018 Aug 16; 10(1):79. PubMed ID: 30111356
    [Abstract] [Full Text] [Related]

  • 9. Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.
    Che XQ, Zhao QH, Huang Y, Li X, Ren RJ, Chen SD, Wang G, Guo QH.
    Curr Alzheimer Res; 2017 Aug 16; 14(10):1102-1108. PubMed ID: 28462717
    [Abstract] [Full Text] [Related]

  • 10. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A, French research network on FTD/FTD-MND.
    Brain; 2008 Mar 16; 131(Pt 3):732-46. PubMed ID: 18245784
    [Abstract] [Full Text] [Related]

  • 11. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS, Adams J, Harris J, Thompson JC, Rollinson S, Richardson A, Jones M, Neary D, Mann DM, Pickering-Brown S.
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar 16; 16(7-8):497-505. PubMed ID: 26473392
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC, Nicholas JM, Heller C, Foiani MS, Moore KM, Russell LL, Paterson RW, Keshavan A, Schott JM, Warren JD, Heslegrave A, Zetterberg H, Rohrer JD.
    Dement Geriatr Cogn Disord; 2020 Mar 16; 49(1):56-76. PubMed ID: 32344399
    [Abstract] [Full Text] [Related]

  • 13. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG, Chalos V, Ghariq E, den Heijer T, Hafkemeijer A, Jiskoot LC, de Koning I, Seelaar H, van Minkelen R, van Osch MJ, Rombouts SA, van Swieten JC.
    Neuroimage Clin; 2016 Mar 16; 12():460-5. PubMed ID: 27625986
    [Abstract] [Full Text] [Related]

  • 14. Thalamic atrophy in frontotemporal dementia - Not just a C9orf72 problem.
    Bocchetta M, Gordon E, Cardoso MJ, Modat M, Ourselin S, Warren JD, Rohrer JD.
    Neuroimage Clin; 2018 Mar 16; 18():675-681. PubMed ID: 29876259
    [Abstract] [Full Text] [Related]

  • 15. Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population.
    Shi Z, Liu S, Xiang L, Wang Y, Liu M, Liu S, Han T, Zhou Y, Wang J, Cai L, Gao S, Ji Y.
    J Hum Genet; 2016 Dec 16; 61(12):1003-1008. PubMed ID: 27439681
    [Abstract] [Full Text] [Related]

  • 16. Genetics of Frontotemporal Dementia.
    Olszewska DA, Lonergan R, Fallon EM, Lynch T.
    Curr Neurol Neurosci Rep; 2016 Dec 16; 16(12):107. PubMed ID: 27878525
    [Abstract] [Full Text] [Related]

  • 17. Motor Speech Phenotypes of Frontotemporal Dementia, Primary Progressive Aphasia, and Progressive Apraxia of Speech.
    Poole ML, Brodtmann A, Darby D, Vogel AP.
    J Speech Lang Hear Res; 2017 Apr 14; 60(4):897-911. PubMed ID: 28289749
    [Abstract] [Full Text] [Related]

  • 18. Mendelian forms of disease and age at onset affect survival in frontotemporal dementia.
    Cosseddu M, Benussi A, Gazzina S, Turrone R, Archetti S, Bonomi E, Biasiotto G, Zanella I, Ferrari R, Cotelli MS, Alberici A, Padovani A, Borroni B.
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb 14; 19(1-2):87-92. PubMed ID: 28990425
    [Abstract] [Full Text] [Related]

  • 19. Genetic screen in a large series of patients with primary progressive aphasia.
    Ramos EM, Dokuru DR, Van Berlo V, Wojta K, Wang Q, Huang AY, Miller ZA, Karydas AM, Bigio EH, Rogalski E, Weintraub S, Rader B, Miller BL, Gorno-Tempini ML, Mesulam MM, Coppola G.
    Alzheimers Dement; 2019 Apr 14; 15(4):553-560. PubMed ID: 30599136
    [Abstract] [Full Text] [Related]

  • 20. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T, Ishii K, Miura T, Mezaki N, Kasuga K, Ikeuchi T, Tamaoka A.
    BMC Neurol; 2017 Sep 15; 17(1):182. PubMed ID: 28915852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.